PathME cluster 3 (green PFS curve) showed the best prognosis of patients and an enrichment of somatic mutations in Isocitrate Dehydrogenase 1 (IDH1), which is a well-known positive prognostic factor in GBM [62]. Here, IDH1 is linked to glioblastoma.